The Pharmacy Times® HIV Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of HIV, a virus that attacks the body's immune system and, if left untreated, can lead to AIDS.

Latest News

3d illustration of HIV virus. Medical concept | Image Credit: artegorov3@gmail -
FDA Approves Label Update for Biktarvy as Treatment of HIV in Pregnant Adults

April 26th 2024

The approval is based on data from Study 5310, evaluating the pharmacokinetics, safety, and efficacy of Biktarvy (Gilead Sciences Inc) in pregnant individuals.

FDA approval seal -- Image credit: Aquir |
FDA Approves Dolutegravir/Lamivudine for Treatment of Adolescents With HIV-1 Infection

April 8th 2024

Concept of FDA Food and Drug Administration | Image Credit: wladimir1804 -
FDA Approves Rilpivirine for Treatment of HIV for Pediatric Patients 2 and Older

March 21st 2024

Pharmacists can address SDOH by recommending screening for at-risk patients, recommending effective medication options for HIV treatment and prophylaxis, providing judgement-free medication counseling, and closely monitoring patients. Image Credit: © jarun011 -
Gilead Set to Donate $12.6 Million In Funding for HIV Prevention for Black Cisgender, Transgender Women

February 29th 2024

HIV positive blood sample | Image Credit: jarun011 -
FDA Approves Expanded Indication for Biktarvy for HIV Treatment

February 26th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.